2012China Foreign Medical TreatmentRequires access

Effects of radiotherapy combined with concurrent weekly paclitaxel in the treatment of patients with esophageal cancer

Wang Yun-xia

Open publisher page 0 citations

Abstract

Objective To study the effect of radiotherapy combined with paclitaxel on esophageal cancer. Methods 50 cases of esophageal cancer were divided into radiotherapy to a total of 60-70Gy; combined group with received the same radiotherapy as simple irradiation group plus chemotherapy with weekly paclitaxel. Both groups were followed for 2years. Results The short-term results of radiotherapy combined with chemotherapy was better than that of radiotherapy alone. The difference between these two groups was statistically (P0.05).The one 、 two year and five year survival rate were 80%、64% in combined. survival rate were 64%、40%in simple irradiation group. The survival rates in the combined group were thus much better than those in simple irradiation group (P0.05). Conclusion Radiotherapy combined with chemotherapy for advanced esophageal cancer is effective and merits further study in the clinic.

About this research paper

What this paper is about

Objective To study the effect of radiotherapy combined with paclitaxel on esophageal cancer. Methods 50 cases of esophageal cancer were divided into radiotherapy to a total of 60-70Gy; combined group with received the same radiotherapy as simple irradiation group plus chemotherapy with weekly paclitaxel. Both groups were followed for 2years. Results The short-term results of radiotherapy combined with chemotherapy was better than that of radiotherapy alone. The difference between these two groups was statistically (P0.05).The one 、 two year and five year survival rate were 80%、64% in combined. survival rate were 64%、40%in simple irradiation group. The survival rates in the combined group were thus much better than those in simple irradiation group (P0.05). Conclusion Radiotherapy combined with chemotherapy for advanced esophageal cancer is effective and merits further study in the clinic.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of radiotherapy combined with paclitaxel on esophageal cancer. Methods 50 cases of esophageal cancer were divided into radiotherapy to a total of 60-70Gy; combined group with received the same radiotherapy as simple irradiation group plus chemotherapy with weekly paclitaxel. Both groups were followed for 2years. Results The short-term results of radiotherapy combined with chemotherapy was better than that of radiotherapy alone. The difference between these two groups was statistically (P0.05).The one 、 two year and five year survival rate were 80%、64% in combined. survival rate were 64%、40%in simple irradiation group. The survival rates in the combined group were thus much better than those in simple irradiation group (P0.05). Conclusion Radiotherapy combined with chemotherapy for advanced esophageal cancer is effective and merits further study in the clinic.

Key concepts: Medicine, Radiation therapy, Paclitaxel, Esophageal cancer, Chemotherapy, Oncology, Survival rate, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of radiotherapy combined with concurrent weekly paclitaxel in the treatment of patients with esophageal cancer — Research Paper | ScholarLens